Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study

Akgun, Zuleyha; Saglam, Sezer; YÜCEL, Serap; Gural, Zeynep; Balik, Emre; Cipe, Gokhan; YILDIZ, ŞEYMA; Kilickap, Sadettin; OKYAR, Alper; Kaytan-Saglam, Esra

doi:10.1007/s00280-014-2558-x

Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study

Akgun Z., Saglam S., YÜCEL S., Gural Z., Balik E., Cipe G., ...More

CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.74, no.4, pp.751-756, 2014 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 74 Issue: 4
Publication Date: 2014
Doi Number: 10.1007/s00280-014-2558-x
Journal Name: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.751-756
Hacettepe University Affiliated: Yes

Abstract

The aim of this study was to evaluate efficacy and safety of chronomodulated capecitabine administered according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.